Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.480
+0.010 (0.68%)
Mar 10, 2026, 10:57 AM HKT
142.62%
Market Cap 13.35B
Revenue (ttm) 2.30B
Net Income (ttm) -88.36M
Shares Out 9.08B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE 23.61
Dividend 0.02 (1.53%)
Ex-Dividend Date Sep 26, 2025
Volume 6,508,000
Average Volume 43,263,528
Open 1.490
Previous Close 1.470
Day's Range 1.480 - 1.520
52-Week Range 0.530 - 1.920
Beta 1.13
RSI 45.84
Earnings Date Mar 27, 2026

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet... [Read more]

Sector Healthcare
Founded 2001
Employees 2,767
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0460
Full Company Profile

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.